AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 20493427 — intervention group
Group type: EXPERIMENTAL
Intervention: Prediction of 60 min ESR based on 30 min ESR
Number of subjects: 220
Study 18981464 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole (Let)
Number of subjects: 2685
Study 18981464 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen (Tam)
Number of subjects: 2685
Study 17125606 — intervention group
Group type: EXPERIMENTAL
Intervention: Foscarnet sodium
Number of subjects: 208
Study 17125606 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 208
Study 14691382 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol consumption
Number of subjects: 300
Study 14691382 — intervention group
Group type: COMPARATOR
Intervention: Placebo beverage
Number of subjects: 300
Study 14691382 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral anger
Number of subjects: 300
Study 10589000 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmeterol powder
Number of subjects: 352
Study 10589000 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 352
Study 7574933 — intervention group
Group type: EXPERIMENTAL
Intervention: Reactive patients (DTH response present)
Number of subjects: 4292
Study 7574933 — intervention group
Group type: EXPERIMENTAL
Intervention: Anergic patients (DTH response absent)
Number of subjects: 4292
Study 7574933 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibody response to protein antigens
Number of subjects: 4292
Study 7574933 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibody response to polysaccharide antigens
Number of subjects: 4292
Study 7574933 — intervention group
Group type: EXPERIMENTAL
Intervention: T cell presence in skin (measured by mRNA signal CD3)
Number of subjects: 4292
Study 7574933 — intervention group
Group type: COMPARATOR
Intervention: Circulating and exudate polymorphonuclear cell function
Number of subjects: 4292
Study 7574933 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental nutrition in anergic patients
Number of subjects: 4292
Study 7574933 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall patient mortality
Number of subjects: 4292
Study 7574933 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced DTH response
Number of subjects: 4292
Study 2009043 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetotherapy
Number of subjects: 47
Study 2009043 — intervention group
Group type: COMPARATOR
Intervention: Control (hot pack applications and passive manual stretching and pulley exercises)
Number of subjects: 47
Study 6110965 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrarectal metronidazole
Number of subjects: 496
Study 6110965 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraincisional povidone iodine
Number of subjects: 496
Study 6110965 — intervention group
Group type: COMPARATOR
Intervention: Untreated control group
Number of subjects: 496
Study 30964435 — intervention group
Group type: EXPERIMENTAL
Intervention: WhatsApp group
Number of subjects: 62
Study 30964435 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 62
Study 27436026 — intervention group
Group type: EXPERIMENTAL
Intervention: Model A (diabetes mellitus, history of urological/nephrological disease, cardiovascular disease, hypertension)
Number of subjects: 1001
Study 27436026 — intervention group
Group type: EXPERIMENTAL
Intervention: Model B (diabetes mellitus, history of urological/nephrological disease, age >75 years, congestive heart failure)
Number of subjects: 1001
Study 25559870 — intervention group
Group type: EXPERIMENTAL
Intervention: i-gel
Number of subjects: 80
Study 25559870 — intervention group
Group type: COMPARATOR
Intervention: air-Q SP
Number of subjects: 80
Study 23994882 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide mononitrate (ISMN) 20 mg retarded release orally twice per day, n=30
Number of subjects: 60
Study 23994882 — intervention group
Group type: COMPARATOR
Intervention: Placebo, n=30
Number of subjects: 60
Study 23994882 — intervention group
Group type: COMPARATOR
Intervention: Comparison of ISMN vs. placebo
Number of subjects: 60
Study 23994882 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study 22314980 — intervention group
Group type: EXPERIMENTAL
Intervention: 500ml of water
Number of subjects: 37
Study 19263918 — intervention group
Group type: EXPERIMENTAL
Intervention: Videophone counseling sessions
Number of subjects: 35
Study 19263918 — intervention group
Group type: COMPARATOR
Intervention: Telephone counseling sessions
Number of subjects: 35
Study 19263918 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse visualization via videophone
Number of subjects: 35
Study 16254590 — intervention group
Group type: EXPERIMENTAL
Intervention: Bimatoprost 0.03% once daily
Number of subjects: 30
Study 16254590 — intervention group
Group type: COMPARATOR
Intervention: Timolol 0.5% twice daily
Number of subjects: 30
Study 14769678 — intervention group
Group type: EXPERIMENTAL
Intervention: Invasive strategy
Number of subjects: 1865
Study 14769678 — intervention group
Group type: COMPARATOR
Intervention: Conservative strategy
Number of subjects: 1865
Study 14769678 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated creatine kinase-MB and troponins
Number of subjects: 1865
Study 14769678 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated high-sensitivity C-reactive protein and brain natriuretic peptide
Number of subjects: 1865
Study 11694921 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1: ASD with removal of only an inferior clavicular osteophyte
Number of subjects: 76
Study 11694921 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 2: Resection of any inferior clavicle spur, violation of the inferior joint capsule, and removal of articular cartilage to a level adjacent with the resected acromion
Number of subjects: 76
Study 11694921 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 3: Complete distal clavicle excision
Number of subjects: 76
Study 9400772 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical 0.1% dexamethasone (DMS)
Number of subjects: 16
Study 9400772 — intervention group
Group type: COMPARATOR
Intervention: Topical 0.1% fluorometholone (FML)
Number of subjects: 16
Study 7959158 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound only (Group I, N=96)
Number of subjects: 120
Study 7959158 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound plus estradiol (Group II, N=24)
Number of subjects: 120
Study 2953865 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone
Number of subjects: 50
Study 2953865 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 29943946 — intervention group
Group type: EXPERIMENTAL
Intervention: Deproteinized bovine bone grafting (test)
Number of subjects: 20
Study 29943946 — intervention group
Group type: COMPARATOR
Intervention: Spontaneous healing (control)
Number of subjects: 20
Study 29943946 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 20
Study 28196169 — intervention group
Group type: EXPERIMENTAL
Intervention: PRF + MCAF
Number of subjects: 20
Study 28196169 — intervention group
Group type: COMPARATOR
Intervention: MCAF with SCTG
Number of subjects: 20
Study 26385039 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk percutaneous coronary intervention (PCI)
Number of subjects: 184
Study 24271093 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional physical therapy (CPT) for airway clearance
Number of subjects: 24
Study 24271093 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasotracheal suction
Number of subjects: 24
Study 24271093 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) without respiratory diseases
Number of subjects: 24
Study 21030369 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid captopril formulations
Number of subjects: 18
Study 21030369 — intervention group
Group type: COMPARATOR
Intervention: Licensed tablet form
Number of subjects: 18
Study 18441854 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapalene 0.1%-BPO 2.5% combination product
Number of subjects: 60
Study 18441854 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapalene 0.1%-BPO 5% combination product
Number of subjects: 60
Study 18441854 — intervention group
Group type: COMPARATOR
Intervention: BPO 2.5% monotherapy
Number of subjects: 60
Study 18441854 — intervention group
Group type: COMPARATOR
Intervention: BPO 5% monotherapy
Number of subjects: 60
Study 18441854 — intervention group
Group type: COMPARATOR
Intervention: BPO 10% monotherapy
Number of subjects: 60
Study 16613208 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery for early gastric cancer
Number of subjects: 0
Study 16613208 — intervention group
Group type: COMPARATOR
Intervention: Open surgery and endoscopic mucosal resection
Number of subjects: 0
Study 12798618 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG-vaccinated children with a BCG scar
Number of subjects: 1813
Study 12798618 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG-vaccinated children with a positive tuberculin test
Number of subjects: 1813
Study 12798618 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG-vaccinated children with a BCG scar after censoring for TB exposure
Number of subjects: 1813
Study 12798618 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG-vaccinated children with a positive tuberculin test after censoring for TB exposure
Number of subjects: 1813
Study 12798618 — intervention group
Group type: COMPARATOR
Intervention: Children positive to tetanus or diphtheria in the skin test
Number of subjects: 1813
Study 10780685 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with β-thalassemia
Number of subjects: 84
Study 10780685 — intervention group
Group type: COMPARATOR
Intervention: Healthy persons (controls)
Number of subjects: 84
Study 10780685 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with β-thalassemia and controls
Number of subjects: 84
Study 10165114 — intervention group
Group type: EXPERIMENTAL
Intervention: Jet spacer device with inhaled beclomethasone dipropionate (0.5 mg twice daily)
Number of subjects: 66
Study 10165114 — intervention group
Group type: COMPARATOR
Intervention: Standard actuator with inhaled beclomethasone dipropionate (0.5 mg twice daily)
Number of subjects: 66
Study 1675577 — intervention group
Group type: EXPERIMENTAL
Intervention: Atipamezole (6.7 micrograms kg-1)
Number of subjects: 6
Study 1675577 — intervention group
Group type: EXPERIMENTAL
Intervention: Atipamezole (27 micrograms kg-1)
Number of subjects: 6
Study 1675577 — intervention group
Group type: EXPERIMENTAL
Intervention: Atipamezole (67 micrograms kg-1)
Number of subjects: 6
Study 1675577 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 6
Study 6824894 — intervention group
Group type: EXPERIMENTAL
Intervention: Filter (0.2 micron filter with hydrophobic and hydrophilic elements)
Number of subjects: 194
Study 6824894 — intervention group
Group type: COMPARATOR
Intervention: Dummy (identical dummy without filtration)
Number of subjects: 194
Study 6824894 — intervention group
Group type: EXPERIMENTAL
Intervention: Filter
Number of subjects: 194
Study 6824894 — intervention group
Group type: COMPARATOR
Intervention: Dummy
Number of subjects: 194
Study 29547019 — intervention group
Group type: EXPERIMENTAL
Intervention: Galvano-puncture (GG)
Number of subjects: 48
Study 29547019 — intervention group
Group type: EXPERIMENTAL
Intervention: Dermabrasion (DG)
Number of subjects: 48
Study 29547019 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 48
Study 29970026 — intervention group
Group type: EXPERIMENTAL
Intervention: Third model (including background variables, MAP, biomarkers, and mean Uta-PI)
Number of subjects: 257
Study 29970026 — intervention group
Group type: EXPERIMENTAL
Intervention: Third model
Number of subjects: 257
Study 29970026 — intervention group
Group type: EXPERIMENTAL
Intervention: Second model (including background variables, MAP, and biomarkers)
Number of subjects: 257
Study 27258294 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking in a city park
Number of subjects: 20
Study 27258294 — intervention group
Group type: COMPARATOR
Intervention: Walking in an urban street environment
Number of subjects: 20
Study 24943285 — intervention group
Group type: EXPERIMENTAL
Intervention: BOLD+ diet (153 g beef per day)
Number of subjects: 36
Study 24943285 — intervention group
Group type: COMPARATOR
Intervention: HAD (20 g beef per day)
Number of subjects: 36
Study 24943285 — intervention group
Group type: EXPERIMENTAL
Intervention: BOLD diet (113 g beef per day)
Number of subjects: 36
Study 24943285 — intervention group
Group type: EXPERIMENTAL
Intervention: DASH diet (28 g beef per day)
Number of subjects: 36
Study 22564271 — intervention group
Group type: EXPERIMENTAL
Intervention: High-level radiation from mobile phone (Experimental Group 1)
Number of subjects: 30
Study 22564271 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximum-level radiation from mobile phone (Experimental Group 2)
Number of subjects: 30
Study 22564271 — intervention group
Group type: COMPARATOR
Intervention: Mobile phone turned off (Control Group)
Number of subjects: 30
Study 20629812 — intervention group
Group type: EXPERIMENTAL
Intervention: Any medication change or therapeutic lifestyle changes counseling
Number of subjects: 0
Study 20629812 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational materials with telephone calls
Number of subjects: 0
Study 20629812 — intervention group
Group type: COMPARATOR
Intervention: Educational materials without telephone calls
Number of subjects: 0
Study 20629812 — intervention group
Group type: COMPARATOR
Intervention: Financial incentive
Number of subjects: 0
Study 20629812 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 18352900 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (1 mL, 8 mg/2 mL)
Number of subjects: 100
Study 18352900 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 16181864 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac subjects (CABG or PCI)
Number of subjects: 82
Study 16181864 — intervention group
Group type: COMPARATOR
Intervention: Control group (no coronary artery disease)
Number of subjects: 82
Study 12020302 — intervention group
Group type: EXPERIMENTAL
Intervention: CEEs, 0.625 mg/d
Number of subjects: 822
Study 12020302 — intervention group
Group type: EXPERIMENTAL
Intervention: CEEs, 0.625 mg/d and MPA, 2.5 mg/d
Number of subjects: 822
Study 12020302 — intervention group
Group type: EXPERIMENTAL
Intervention: CEEs, 0.45 mg/d
Number of subjects: 822
Study 12020302 — intervention group
Group type: EXPERIMENTAL
Intervention: CEEs, 0.45 mg/d and MPA, 2.5 mg/d
Number of subjects: 822
Study 12020302 — intervention group
Group type: EXPERIMENTAL
Intervention: CEEs, 0.45 mg/d and MPA, 1.5 mg/d
Number of subjects: 822
Study 12020302 — intervention group
Group type: EXPERIMENTAL
Intervention: CEEs, 0.3 mg/d
Number of subjects: 822
Study 12020302 — intervention group
Group type: EXPERIMENTAL
Intervention: CEEs, 0.3 mg/d and MPA, 1.5 mg/d
Number of subjects: 822
Study 12020302 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 822
Study 9792383 — intervention group
Group type: EXPERIMENTAL
Intervention: Test treatment
Number of subjects: 24
Study 9792383 — intervention group
Group type: COMPARATOR
Intervention: Control treatment
Number of subjects: 24
Study 7712301 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole (20 mg daily for 4 weeks) + Amoxycillin (1 g three times daily for 2 weeks) + Metronidazole (1 g daily for 2 weeks)
Number of subjects: 37
Study 7712301 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 7712301 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole + Antibiotics
Number of subjects: 37
Study 2541397 — intervention group
Group type: EXPERIMENTAL
Intervention: NTM skin test antigens
Number of subjects: 11
Study 2541397 — intervention group
Group type: COMPARATOR
Intervention: Purified protein derivative (control)
Number of subjects: 11
Study 238790 — intervention group
Group type: EXPERIMENTAL
Intervention: Clemastine (1 mg b.d.)
Number of subjects: 100
Study 238790 — intervention group
Group type: COMPARATOR
Intervention: Chlorpheniramine (4 mg b.d.)
Number of subjects: 100
Study 238790 — intervention group
Group type: EXPERIMENTAL
Intervention: Clemastine elixir (0.5 mg b.d.)
Number of subjects: 100
Study 238790 — intervention group
Group type: COMPARATOR
Intervention: Chlorpheniramine syrup (2 mg b.d.)
Number of subjects: 100
Study 29678585 — intervention group
Group type: COMPARATOR
Intervention: Metal‐ceramic (MC, control)
Number of subjects: 50
Study 29678585 — intervention group
Group type: EXPERIMENTAL
Intervention: Lava Zirconia (LZ, bi‐layered)
Number of subjects: 50
Study 29678585 — intervention group
Group type: EXPERIMENTAL
Intervention: Lava Plus (LM, monolithic)
Number of subjects: 50
Study 29678585 — intervention group
Group type: EXPERIMENTAL
Intervention: VITA In‐Ceram YZ (YZ, bi‐layered)
Number of subjects: 50
Study 29678585 — intervention group
Group type: EXPERIMENTAL
Intervention: IPS e‐max ZirCAD (ZZ, bi‐layered)
Number of subjects: 50
Study 28179916 — intervention group
Group type: EXPERIMENTAL
Intervention: Mineral Trioxide Aggregate (MTA)
Number of subjects: 47
Study 28179916 — intervention group
Group type: COMPARATOR
Intervention: Calcium-Enriched Mixture (CEM) cement
Number of subjects: 47
Study 28179916 — intervention group
Group type: EXPERIMENTAL
Intervention: Both MTA and CEM cement
Number of subjects: 47
Study 25143342 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronutrient powder (MNP) containing 2.5 mg iron as NaFeEDTA
Number of subjects: 115
Study 25143342 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronutrient powder (MNP) containing 12.5 mg iron as ferrous fumarate
Number of subjects: 115
Study 25143342 — intervention group
Group type: COMPARATOR
Intervention: Micronutrient powder without iron (control)
Number of subjects: 115
Study 23706947 — intervention group
Group type: EXPERIMENTAL
Intervention: DEX implant plus laser treatment
Number of subjects: 253
Study 23706947 — intervention group
Group type: COMPARATOR
Intervention: Laser treatment alone
Number of subjects: 253
Study 23706947 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination treatment
Number of subjects: 253
Study 20568447 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture combined with Chinese herbs
Number of subjects: 0
Study 20568447 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 0
Study 20568447 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 0
Study 20568447 — intervention group
Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 0
Study 18227366 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion hydrochloride therapy with smoking counseling
Number of subjects: 245
Study 18227366 — intervention group
Group type: EXPERIMENTAL
Intervention: Low BDI scores
Number of subjects: 245
Study 18227366 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate to severe depressive symptoms
Number of subjects: 245
Study 16607469 — intervention group
Group type: EXPERIMENTAL
Intervention: Subthalamic Nucleus Deep Brain Stimulation (STN‐DBS)
Number of subjects: 15
Study 14667957 — intervention group
Group type: EXPERIMENTAL
Intervention: Eptifibatide + Unfractionated Heparin (UFH)
Number of subjects: 14
Study 14667957 — intervention group
Group type: EXPERIMENTAL
Intervention: Eptifibatide + Enoxaparin
Number of subjects: 14
Study 11700258 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRHA plus low-dose add-back estrogen-progestin
Number of subjects: 21
Study 11700258 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 21
Study 9136842 — intervention group
Group type: EXPERIMENTAL
Intervention: Pancreatin
Number of subjects: 26
Study 9136842 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 9136842 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraileal nutrient perfusion
Number of subjects: 26
Study 7870745 — intervention group
Group type: EXPERIMENTAL
Intervention: Mianserin (60 mg/day in three oral doses)
Number of subjects: 2
Study 7870745 — intervention group
Group type: COMPARATOR
Intervention: Amitriptyline (75 mg/day in three oral doses)
Number of subjects: 2
Study 3367336 — intervention group
Group type: EXPERIMENTAL
Intervention: Nipple stimulation contraction stress test
Number of subjects: 186
Study 3367336 — intervention group
Group type: COMPARATOR
Intervention: Nonstress test
Number of subjects: 186
Study 1958436 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard nicardipine (STD) 30 mg three times daily for 28 days
Number of subjects: 60
Study 1958436 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained release nicardipine (SR) 60 mg twice daily for 28 days
Number of subjects: 60
Study 1958436 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 616212 — intervention group
Group type: EXPERIMENTAL
Intervention: CO inhalation (1100 ppm CO-air mixture)
Number of subjects: 14
Study 616212 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarette smoking
Number of subjects: 14
Study 616212 — intervention group
Group type: COMPARATOR
Intervention: Air breathing
Number of subjects: 14
Study 30216734 — intervention group
Group type: EXPERIMENTAL
Intervention: Hall technique (HT)
Number of subjects: 132
Study 30216734 — intervention group
Group type: COMPARATOR
Intervention: Conventional restoration (CR)
Number of subjects: 132
Study 27591965 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital alteration disclaimer label
Number of subjects: 280
Study 27591965 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-exposure message about digital alteration
Number of subjects: 280
Study 27591965 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of disclaimer label and pre-exposure message
Number of subjects: 280
Study 27591965 — intervention group
Group type: COMPARATOR
Intervention: Control message
Number of subjects: 280
Study 26338956 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivabradine at 7.5 mg twice daily
Number of subjects: 22
Study 26338956 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 26338956 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivabradine
Number of subjects: 22
Study 23407644 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK424887
Number of subjects: 0
Study 23407644 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram (positive control)
Number of subjects: 0
Study 21682858 — intervention group
Group type: EXPERIMENTAL
Intervention: On-site Biostatistics course (3.5 days)
Number of subjects: 58
Study 21682858 — intervention group
Group type: COMPARATOR
Intervention: On-line Biostatistics course (3.5 weeks)
Number of subjects: 58